glp 1 discovery The GLP-1 revolution: What UAB researchers are discovering about how these drugs work Discovery of novel glucagon-like peptide

The animals were then fed ad libitum under continued treatment with I-M-150847 for a period of 4 weeks after which the body weight was measured

The key point is that regain is gradual and can be mitigated with strategic interventions

While this basic understanding is helpful it doesnt really tell you which is the right choice for you

[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Dailey MJ, Moran TH

Diabetes Obes Metab Seferovi PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, avuolu Y, Polovina M, Metra M, Ambrosio G, Prasad K, Seferovi J, Jhund PS, Dattilo G, elutkiene J, Piepoli M, Moura B, Chioncel O, Ben Gal T, Heymans S, de Boer RA, Jaarsma T, Hill L, Lopatin Y, Lyon AR, Ponikowski P, Lainak M, Jankowska E, Mueller C, Cosentino F, Lund L, Filippatos GS, Ruschitzka F, Coats AJS, Rosano GMC (2020) Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control

Resmetirom received FDA approval for the fibrotic stage, but the steatosis stage, where the vast majority of patients sit, has no approved pharmacological intervention